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Dynamic control of proinﬂammatory cytokines Il-1β
and Tnf-α by macrophages in zebraﬁsh spinal cord
regeneration
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Spinal cord injury leads to a massive response of innate immune cells in non-regenerating
mammals, but also in successfully regenerating zebraﬁsh. However, the role of the immune
response in successful regeneration is poorly deﬁned. Here we show that inhibiting inﬂam-
mation reduces and promoting it accelerates axonal regeneration in spinal-lesioned zebraﬁsh
larvae. Mutant analyses show that peripheral macrophages, but not neutrophils or microglia,
are necessary for repair. Macrophage-less irf8 mutants show prolonged inﬂammation with
elevated levels of Tnf-α and Il-1β. Inhibiting Tnf-α does not rescue axonal growth in irf8
mutants, but impairs it in wildtype animals, indicating a pro-regenerative role of Tnf-α. In
contrast, decreasing Il-1β levels or number of Il-1β+ neutrophils rescue functional regenera-
tion in irf8 mutants. However, during early regeneration, interference with Il-1β function
impairs regeneration in irf8 and wildtype animals. Hence, inﬂammation is dynamically con-
trolled by macrophages to promote functional spinal cord regeneration in zebraﬁsh.
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Zebraﬁsh, in contrast to mammals, are capable of functionalspinal cord regeneration after injury. Recovery of swim-ming function critically depends on regeneration of axonal
connections across the complex non-neural injury site1,2. It is
therefore important to determine the factors that allow axons to
cross the lesion site in zebraﬁsh.
In mammals, a prolonged immune response, consisting of pro-
inﬂammatory macrophages3, microglia cells4 and neutrophils5
together with cytokines released from other cell types, such as
endothelial cells, oligodendrocytes, or ﬁbroblasts6 contribute to
an inhibitory environment for axonal regeneration. However,
activated macrophages can also promote axonal regeneration7–9,
suggesting complex roles of the immune response after spinal
injury.
In zebraﬁsh, we can dissect the roles of these cell types in
successful functional spinal cord repair10. Zebraﬁsh possess an
innate immune system from early larval stages and develop an
adaptive immune system at juvenile stages, similar to those in
mammals11. Indeed, microglia is activated after spinal cord injury
in adult12,13 and larval zebraﬁsh14, suggesting functions of innate
immune cells in repair. Adaptive immunity is also important for
spinal cord regeneration15.
Larval zebraﬁsh regenerate more rapidly than adults. Axonal
and functional regeneration is observed within 48 h after spinal
cord injury in 3 day-old larvae1,2. At the same time, the larval
system presents complex tissue interactions that allow us to
analyse how axons cross a non-neural lesion environment. For
example, axons encounter Pdgfrb+ ﬁbroblast-like cells that
deposit regeneration-promoting Col XII in the lesion site in a
Wnt-signalling dependent manner1. These cells and molecules
are present also in the injury sites of adult zebraﬁsh and
mammals1,6. How immune cells contribute to this growth-
conducive lesion site environment in zebraﬁsh is unclear.
Here we show that peripheral macrophages control axonal
regeneration by producing pro-regenerative tumour necrosis
factor alpha (Tnf-α) and by reducing levels of interleukin-1 β (Il-
1β). While early expression of il-1β promotes axonal regenera-
tion, prolonged high levels of Il-1β in the macrophage-less irf8
mutant are detrimental. Preventing formation of Il-1β producing
neutrophils or inhibiting excess il-1β directly, largely restored
repair in irf8 mutants. This indicates that regulation of a single
immune system-derived factor, Il-1β, is a major determinant of
successful spinal cord regeneration.
Results
The immune response coincides with axonal regeneration. We
analysed axonal regrowth in larval zebraﬁsh that underwent
complete spinal cord transection at 3 days post-fertilisation (dpf)
in relation to invasion of the injury site by different cell types.
Axons were present in the injury site by 1 day post-lesion (dpl).
The thickness of the axonal bundle that connects the injured
spinal cord increased up to 2 dpl and thereafter plateaued for up
to at least 4 dpl (Supplementary Fig. 1A). The thickness of the
connecting axon bundle positively correlated with the recovery of
touch-evoked swimming distance for individual animals at 2 dpl
(Supplementary Fig. 2A–C). This is consistent with previous
results showing continuous axon labelling over the lesion site
(axon bridging) in 80% of animals by 2 dpl, which then plateaued.
Presence of an axon bridge correlates with functional recovery, as
animals without axon bridge showed worse recovery of touch-
evoked swimming distance1 and re-lesioning abolished functional
recovery14. Hence, a percent score of larvae with bridged injury
sites is a quick and reliable measure for anatomical repair1,14.
After injury, we observed a rapid and massive inﬂux of
immune cells, with neutrophils (Mpx+) peaking at 2 h post-lesion
(hpl) and macrophages (mpeg1:GFP+; 4C4-) and microglia
(mpeg1:GFP+; 4C4+) accumulating in the lesion site a few hours
later and peaking at 2 dpl (Fig. 1a, Supplementary Movie 1).
Myelinating cells (cldnK:GFP+) and endothelial cells (ﬂi1:GFP+)
were not abundant in the lesion site during axonal regrowth
(Supplementary Fig. 1C, D), in contrast to functionally important
pdgfrb:GFP+ ﬁbroblasts1 that were present in the lesion site at 1
dpl, peaking at 2 dpl (Supplementary Fig. 1B). This suggests that
myelinating cells and endothelial cells are not essential for axon
bridging. However, at later time points after injury, axons were
clearly associated with processes of myelinating cells (Supple-
mentary Fig. 1C), which may impact functional repair. In
contrast, the spatio-temporal pattern of immune cell invasion
of the injury site suggests an early role for the immune system in
orchestrating axon growth over the lesion site.
Immune system activation promotes axonal regeneration. To
determine the importance of the immune reaction, we inhibited it
using the anti-inﬂammatory synthetic corticosteroid dex-
amethasone14. This reduced the number of microglia14, macro-
phages and neutrophils in the injury site (Fig. 1b–d) and the
proportion of larvae exhibiting axon bridging (control: 78% of
examined animals, dexamethasone: 30%; Fig. 1e). The average
thickness of axon bridges was also reduced by dexamethasone
treatment and correlated with impaired recovery of touch-evoked
swimming distance. (Supplementary Fig. 2A–C). gfap:GFP+
astroglia-like processes that cross the injury site slightly later than
axons1 also showed reduced bridging, from 77.6% of examined
animals to 48.3% (Supplementary Fig. 2D) under dexamethasone
treatment. In addition, depleting the number of immune cells
with a well-established morpholino combination against pu.1 and
gcsfr16 reduced the proportion of larvae with axonal bridges from
81% of examined animals to 57% (Supplementary Fig. 3A, B).
For a gain-of-function approach, we used incubation with
bacterial lipopolysaccharides (LPS)17. This increased the number
of neutrophils and macrophages in the lesion site (Fig. 1f–h). To
detect a potential accelerating effect on axonal regrowth, we
analysed larvae at 18 hpl, when axonal regeneration was
incomplete in untreated animals. This showed an increase in
the proportion of larvae with axonal bridges from 41% of
examined animals in wildtype to 60% in LPS-treated animals
(Fig. 1i). Hence, immune system activity is necessary for and
promotes axonal regeneration across a spinal lesion site.
Macrophages determine regenerative success. To analyse the
role of different immune cell types in repair, we used mutants. In
mutants for the macrophage-lineage determining transcription
factor irf8, macrophages and microglial cells, but not neutrophils
are missing during early development18. Homozygous mutants
are adult viable and show no overt developmental aberrations,
except for an increased number of neutrophils18. In situ hybri-
disation for the macrophage and microglia marker mpeg1 con-
ﬁrmed expression in the ventral trunk of unlesioned larvae and in
a spinal lesion site at 2 dpl in wildtype larvae, but complete
absence of signal in unlesioned and lesioned irf8 larvae (Fig. 2a).
Next, we determined axonal regrowth and recovery of
parameters of swimming capacity in irf8 mutants compared to
wildtype animals. Wildtype and mutants showed comparable
proportions of animals with axon bridges at 1 dpl (wildtype: 44%
of examined animals; irf8 mutant: 43%). At 2 dpl, however,
axonal continuity was observed in 80% of wildtype animals but
only in 41% of irf8mutants (Fig. 2b). At 5 dpl–2.5 times as long as
wildtype animals need for maximal axon bridging—the propor-
tion of mutant larvae with bridged lesion sites was increased
compared to 2 dpl (55% of examined animals vs. 41%), but
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regenerative success was still strongly reduced compared to
wildtype controls (55% of examined animals vs. 87%; Fig. 2c).
Analysing touch-evoked swimming, we found that wildtype
animals swam comparable distances to unlesioned controls at 2
dpl, as previously described1. In contrast, recovery of touch-
evoked swimming distance in irf8 larvae plateaued at 2 dpl and
did not reach levels of unlesioned animals to at least 5 dpl
(Fig. 2c). This indicates that in the absence of macrophages and
microglia in irf8 mutants, initial axonal regeneration is unaf-
fected, but axonal regrowth and functional recovery after spinal
cord injury are impaired long-term.
To determine the importance of microglia for regeneration, we
analysed csf1ra/b double-mutants (see Methods) in which the
function of colony-stimulating factor 1 receptor (Csf1r) is
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Fig. 1 Spinal injury leads to an inﬂammatory response that promotes axonal regeneration. a Neutrophils, macrophages, and microglial cells show different
dynamics after injury. Neutrophils (Mpx+) accumulate in the injury site very early, peaking at 2 hpl. Macrophages (mpeg1:GFP+/4C4−) and microglial cell
(mpeg1:GFP+/4C4+) numbers peak at 48 hpl. Fluorescence images were projected onto transmitted light images. b–e Incubation with dexamethasone
(timeline in b) reduces neutrophil and macrophage numbers (c, d; Mann–Whitney U-test: **P < 0.01, ***P < 0.001), as well as the proportion of animals
with axonal bridging (e; Fisher’s exact test: ***P < 0.001). f–i, Incubation of animals with LPS during early regeneration (timeline in f) increased numbers of
neutrophils and macrophages (g, h; t-test: **P < 0.01, ***P < 0.001), as well as the proportion of animals with axonal bridging at 24 hpl (i Fisher’s exact test:
*P < 0.05). Lateral views of the injury site are shown; rostral is left. Rectangles indicate region of quantiﬁcation; arrows indicate axonal bridging. Scale bars:
50 μm; Error bars indicate SEM
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compromised. Csf1r is selectively needed for microglia differ-
entiation19. After injury in csf1ra/b mutants, we observed a strong
reduction in the number of microglial cells (to 17% of wildtype),
but an increase in macrophage numbers (by 55% compared to
wildtype) in the injury site (Fig. 3a, c). Interestingly, neutrophil
numbers were also strongly reduced (to 64.1% of wildtype at 2 hpl
and 16% at 1 dpl) (Fig. 3b), perhaps due to feedback regulation
from increased macrophage numbers. Whereas microglia cells
were reduced in number in the entire ﬁsh, neutrophils were
still present in the ventral trunk area. In these mutants, axon
bridging was unimpaired (Fig. 3d). Hence, microglia are not
necessary for axonal regeneration and reduced numbers of
neutrophils do not negatively affect axonal regrowth. Combined
with results from the irf8 mutant, this indicates that recruitment
of peripheral macrophages is critical for successful spinal cord
regeneration.
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Macrophages are not necessary for Col XII deposition. Next, we
asked whether macrophages act via a previously reported
regeneration-promoting mechanism, comprising Wnt-dependent
deposition of Col XII in the lesion site by pdgfrb:GFP+ ﬁbroblast-
like cells1. Inhibition of the immune response with dex-
amethasone did not inhibit appearance of pdgfrb:GFP+
ﬁbroblast-like cells in the lesion site (Supplementary Fig. 4A). By
crossing a reporter line for Wnt pathway activity (6xTCF:dGFP)1
into the irf8 mutant, we found that activation of the pathway was
unaltered in the mutant (Supplementary Fig. 4E). Similarly,
expression of col12a1a and col12a1b mRNA in irf8 mutants was
indistinguishable from that in wildtype animals (Supplementary
Fig. 4B). Deposition of Col I protein and mRNA expression of 11
other ECM components were also not altered in the irf8 mutant
at 1 and 2 dpl (Supplementary Fig. 4B, C). Moreover, immuno-
labelling against Tp63 showed that by 2 dpl, the injury site in the
irf8 mutants was completely covered by basal keratinocytes, an
additional source of Col XII1, as in wildtype animals (Supple-
mentary Fig. 4D). In contrast, a PCR screen of 21 potentially
macrophage-derived ECM-modifying matrix metalloprotei-
nases20 (mmps) indicated lower mRNA levels for mmp11a,
mmp16a/b, mmp24, and mmp28 in the injury site of irf8 mutants
compared to wildtype animals (Supplementary Fig. 5A, B). This
suggests a potential for macrophages to alter the lesion site ECM
with Mmps. Overall, macrophages do not overtly regulate Wnt-
signalling, deposition of some crucial ECM components or basal
keratinocyte coverage of the injury site during regeneration.
Cellular debris is not a major impediment to regeneration.
Macrophages could serve as a substrate for axon growth or
promote regeneration by removing debris by phagocytosis—a
major function of macrophages in peripheral nerve regeneration
in zebraﬁsh21,22. In time-lapse movies of double transgenic ani-
mals in which neurons (Xla.Tubb:DsRed) and macrophages
(mpeg1:GFP) were labelled (Supplementary Fig. 6B and Supple-
mentary Movie 2) we observed axons crossing the spinal lesion
site at the same time macrophages migrated in and out of the
injury site. However, no obvious physical interactions between
these cell types were observed, making it unlikely that macro-
phages acted as an axon growth substrate.
We frequently observed macrophages ingesting neuronal
material and transporting that away from the injury site in
time-lapse movies (Supplementary Fig. 6B and Supplementary
Movie 2). In agreement with this observation, TUNEL labelling
indicated strongly increased levels of dead or dying cells in the
late (48 hpl), but not the early (24 hpl) phase of axonal
regeneration in the injury site of irf8 mutants (Supplementary
Fig. 6A).
To determine the impact of debris on regeneration, we
prevented cell death and consequently debris accumulation in
irf8 larvae using the pan-caspase inhibitor QVD23, that is
functional in zebraﬁsh24. This treatment led to lower debris
levels that were comparable to those seen in wildtype larvae at 2
dpl (Supplementary Fig. 6C), but failed to increase regenerative
success in irf8 mutants (control, 38% of examined larvae with
axon bridges; QVD, 40%. Thickness of axon bridge: control 19.03
+/−2.14 µm; QVD: 18.32+/−2.53 µm; t-test: P > 0.05. Supple-
mentary Fig. 6E). Conversely, inhibiting debris phagocytosis with
the pharmacological inhibitor O-phospho-L-serine (L-SOP)25 in
wildtype animals increased levels of debris in the injury site, but
did not impair axonal bridging (Supplementary Fig. 7A–C). This
suggests no obvious connection between debris levels and/or
phagocytosis and regenerative success.
Pro-and anti-inﬂammatory phases are altered in irf8 mutants.
To determine a possible role of cytokines in the regenerative
failure of irf8 mutants, we analysed relative levels of pro-and anti-
inﬂammatory cytokines in the lesion site during regeneration in
wildtype animals and irf8 mutants by qRT-PCR. In wildtype
animals, expression levels of pro-inﬂammatory cytokines il-1β
and tnf-α were high during initial regeneration (>25-fold for il-
1β; >12-fold for tnf-α for approximately to 12 hpl) and reduced
again during late regeneration (12–48 hpl), although still elevated
compared to unlesioned controls (Fig. 4a, b). Anti-inﬂammatory
cytokines, such as tgf-β1a and tgf-β3 were expressed at low levels
during initial regeneration, and upregulated during late regen-
eration (approximately 3-fold for tgf-β1a and 2-fold for tgf-β3),
indicating a bi-phasic immune response within the 48-h time
frame of analysis (Fig. 4c, d).
In irf8 mutants, levels of pro-inﬂammatory cytokines remained
high during the late phase of regeneration (Fig. 4a, b) and anti-
inﬂammatory cytokines were not upregulated (Fig. 4c, d),
resulting in a sustained pro-inﬂammatory environment in irf8
mutants.
The lack of anti-inﬂammatory cytokines correlated with the
lack of macrophages and microglia in irf8 mutants. We
performed qRT-PCR in ﬂuorescence activated ﬂow sorted
mpeg1:GFP cells in wildtype animals to determine whether
macrophages and microglial cells expressed tgf-β1a and tgf-β3.
mpeg1:GFP+ cells, but also mpeg1:GFP– cells expressed these
cytokines (Supplementary Fig. 8A). In situ hybridisation showed
wide-spread labelling with some more strongly labelled cells
around the injury site in wildtype, but not irf8 mutants
(Supplementary Fig. 8B). This is consistent with expression of
tgf-β1a and tgf-β3 in microglia/macrophages and other cell
types26. Hence, the immune response is bi-phasic with an initial
pro-inﬂammatory phase, followed by an anti-inﬂammatory phase
in wildtype animals. In the absence of macrophages in irf8
mutants, animals fail to switch to an anti-inﬂammatory state.
Tnf-α promotes axonal regeneration. To determine whether
increased levels of pro-inﬂammatory cytokines contributed to
impaired axon growth in irf8 mutants, we ﬁrst inhibited Tnf-α
signalling. Pomalidomide, a pharmacological inhibitor of Tnf-α
release27, had no effect on axonal regrowth in irf8 mutants. In
Fig. 2 In the irf8 mutant, axonal regeneration and functional recovery after injury show long-term impairment. a In situ hybridisation for mpeg1 conﬁrms the
absence of macrophages and microglial cells before and after injury in the irf8 mutant compared to controls. Arrows indicate labelling around the injury site
and brackets indicate the ventral area of the larvae where the macrophages can be found in the circulation. Note that blackish colour is due to melanocytes.
b Quantiﬁcation of the proportion of larvae with axonal bridging (anti-acetylated Tubulin) shows that at 1 dpl, axonal bridging is unimpaired in irf8 mutants,
whereas at 2 dpl, irf8 mutants fail to show full regrowth and even by 5 dpl, the proportion of irf8 larvae with a bridged lesion site is still lower than in
wildtype controls (Fisher’s exact test: ***P < 0.001, n.s. indicated no signiﬁcance). c Irf8 mutants never fully recover touch-evoked swimming distance in the
observation period, whereas wildtype control animals do. Representative swim tracks are displayed. Note that unlesioned irf8 larvae show swimming
distances that are comparable to those in wildtype controls (Two-way ANOVA: F15,1372= 11.42, P < 0.001; unles.= unlesioned, les.= lesioned). All lesions
are done at 3 dpf. Lateral views of the injury site are shown; rostral is left. Arrows indicate axonal bridging. Scale bars: 200 μm in a and 50 μm in c. Error
bars indicate SEM
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contrast, in wildtype animals Pomalidomide strongly inhibited
axon bridging at 1 dpl (control: 62% of examined animals showed
an axonal bridge; Pomalidomide: 36%) and 2 dpl (control: 75% of
examined animals; Pomalidomide: 45%) (Fig. 5a).
To conﬁrm pharmacological results, we targeted tnf-α by using
CRISPR manipulation with a gene-speciﬁc guideRNA (gRNA).
Injection of the gRNA into the zygote efﬁciently mutated the gene
as shown by restriction fragment length polymorphism (RFLP)
analysis (Fig. 5b) and produced function-disrupting insertion-
deletion mutations in a highly conserved domain28 (Supplemen-
tary Table 1). Western blots of 4-day old larvae and immuno-
histochemistry in the injury site showed robustly reduced Tnf-α
protein levels (Supplementary Fig. 9A, B).
Axon bridging was inhibited in wildtype animals by tnf-α
gRNA injection in a way that was comparable to drug treatment
(1 dpl: control: 51% of examined animals showed bridging;
gRNA: 27%; 2 dpl: control: 88% of examined animals showed
bridging; gRNA: 40%). At 5 dpl, axon bridging was still strongly
impaired (control: 84.1% of examined animals showed bridging;
gRNA: 38.3%; Fig. 5c), indicating long-term impairment of
regeneration. Hence, tnf-α dysregulation is not a major cause of
regenerative failure in irf8 mutants, but tnf-α is necessary for
axonal regeneration in wildtype animals.
To determine which cells expressed tnf-α in wildtype animals,
we used immunohistochemistry for L-Plastin, labelling all
immune cells, in tnf-α:GFP transgenic ﬁsh (Fig. 6d). Nearly all
tnf-α:GFP+ cells co-labelled with L-Plastin (96%) at 12 hpl. Thus,
expression of tnf-α occurred mainly in immune cells (Fig. 6a).
Double-labelling tnf-α:GFP reporter ﬁsh with neutrophil (Mpx),
microglia (4C4) and macrophage (Mfap4) markers at 24 hpl,
when axons were actively growing, indicated that >95% of tnf-α:
GFP+ cells in the injury were peripheral macrophages. However
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other cell types, such as neurons29, may also express tnf-α. More
than 72% of macrophages were tnf-α:GFP+, whereas for
microglia (<6.5%) and neutrophils (<0.7%) the proportion was
much smaller. Over time, the proportion of tnf-α:GFP+
macrophages was reduced (from 72.5% at 1 dpl to 59% at 2
dpl) (Fig. 6b). Our observations suggest that macrophages
promote regeneration by expressing tnf-α.
To elucidate effects of tnf-α inhibition, we determined numbers
of neutrophils and macrophages/microglia at 24 and 48 hpl in tnf-α
gRNA injected animals. This showed no changes in macrophages,
but a 49.7% increase in the number of neutrophils at 1 dpl (Fig. 6c).
qRT-PCR indicated that il-1β mRNA levels were increased by
108%, whereas tnf-α, tgf-β1a and tgf-β3 mRNA levels remained
unchanged at 2 dpl (Fig. 6d). This suggests a moderate enhance-
ment of the pro-inﬂammatory response when Tnf-α is inhibited.
Il-1β inhibits regeneration in irf8 mutants. To test whether
sustained high levels of Il-1β were responsible for regenerative
failure in irf8 mutants, we interfered with il-1β function in three
different ways. Firstly, we inhibited caspase-1, which is necessary
for activation of Il-1β, using the pharmacological inhibitor YVAD
that is functional in zebraﬁsh30 (Fig.7a–e). Secondly, we disrupted
il-1β RNA splicing with an established morpholino (Supple-
mentary Fig. 10A–D)31. Finally, we targeted il-1β in a CRISPR
approach (Supplementary Fig. 10E–H).
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To determine whether interfering with Il-1β function mitigated
inﬂammation in irf8 mutants, we quantiﬁed immune cells,
expression of il-1β, tnf-α, and dead cells. Indeed, after YVAD
treatment we observed a reduction of neutrophil peak numbers
(by 38% at 2 hpl; Fig. 7b), as well as strongly reduced levels of il-
1β and tnf-α mRNA expression (at 2 dpl; Fig. 7a) in irf8 mutants.
Moreover, the number of TUNEL+ cells was reduced at 2 dpl in
the irf8 mutant, but not to wildtype levels (Fig. 7c). In lesioned
wildtype animals, YVAD reduced peak numbers of neutrophils
(by 40% at 2 hpl) and macrophages (by 28% at 48 hpl), but no
inﬂuence on low numbers of TUNEL+ cells at 2 dpl was observed.
Hence, interfering with Il-1β function reduces inﬂammation in
irf8 mutants and wildtype animals.
Axon bridging in wildtype animals was not affected by YVAD
treatment at 2 dpl (control: 79% of examined animals showed
bridging; YVAD: 78%) (Fig. 7d), indicating that high levels of Il-
1β were not necessary for axonal regeneration. In contrast, in
YVAD-treated irf8 mutants, we observed a remarkable rescue of
axon bridging at 2 dpl (control: 38% of examined animals showed
bridging; YVAD: 69%) (Fig. 7d).
Injecting a well-established31 morpholino targeting il-1β into
irf8 mutants at the one-cell-stage inhibited il-1β splicing
(Supplementary Fig. 10A, D). Morpholino-injected animals
showed a rescue of axon bridging at 2 dpl (control: 40% of
examined animals showed bridging; YVAD: 60%) (Supplemen-
tary Fig. 10B, C).
Finally, injecting a gRNA targeting il-1β at the one-cell stage
led to somatic mutation in the target site of il-1β, indicated by
RFLP analysis (Supplementary Fig. 10E, H). This strongly rescued
axonal bridging in lesioned irf8 mutants (control: 40% of
examined animals showed bridging; acute il-1β gRNA: 70%)
(Supplementary Fig. 10F, G). Hence, three independent manip-
ulations show that excessive il-1β levels in irf8 mutants are a key
reason for impaired axonal regeneration.
Il-1β promotes axonal regeneration during the early regen-
eration. To determine whether roles of Il-1β and general inﬂam-
mation differed for different phases of the inﬂammation, we
separately analysed early (0–1 dpl; Supplementary Fig. 11A) and
late (1–2 dpl; Supplementary Fig. 11B) regeneration by drug incu-
bation. During the early phase, YVAD treatment led to a weak
inhibition of axonal regeneration in both wildtype (control: 58% of
examined animals showed bridging; YVAD: 41%) and irf8 mutants
(control: 41% of examined animals showed bridging; YVAD: 36%).
Similarly, dexamethasone treatment inhibited axonal regeneration
in both wildtype (control: 57.5% of examined animals showed
bridging; dexamethasone: 36.6%) and irf8 (control: 44.6% of
examined animals showed bridging; dexamethasone: 34%). Inter-
estingly, while LPS promoted regeneration in the early phase in
wildtype animals (control: 53.2% of examined animals showed
bridging; LPS: 68.7%), it was detrimental in irf8 mutants (control:
39% of examined animals showed bridging; LPS: 25.5%), perhaps
because baseline inﬂammation was already high in the mutant.
During late regeneration, only dexamethasone had an
inhibitory effect in wildtype animals (from 82.1% of examined
animals that showed bridging to 64.4%). YVAD had no effect in
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wildtype animals during late regeneration, when il-1β was already
down-regulated (control: 81% crossing; YVAD: 78% crossing),
but a strong rescue effect of YVAD was observed in the irf8
mutant (control: 37% of examined animals showed bridging;
YVAD: 68%). This rescue effect was comparable to that observed
when Il-1β was suppressed for the entire 48 h (cf. Fig. 7d). LPS
had no effect in wildtype or mutants during late regeneration.
Hence, early inﬂammation and il-1β upregulation promote
regeneration, but il-1β must be down-regulated at later phases
of axonal regeneration.
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Fig. 6 Tnf-α is expressed by macrophages and regulates the immune response. a Top row: tnf-α:GFP labelling occurs almost exclusively in L-plastin+
immune cells (L-plastin in green; tnf-α:GFP in magenta; yellow arrow indicates a rare tnf- α:GFP+ microglial cell; 12 hpl) b In the injury site, the number and
proportion of macrophages (Mfap4+) that are tnf-α:GFP+ are much higher than numbers and proportions of microglia (4C4+) and neutrophils (Mpx+),
indicating that the main source of Tnf-α is the macrophages. Arrows indicate double-labelled cells and arrowheads indicate immune cells that are tnf-α:
GFP-. Single optical sections are shown; the proportion of macrophages that are tnf-α:GFP+ decreases over time, whereas the proportion of tnf-α:GFP+
microglial cells slightly increases (One-way ANOVA followed by Bonferroni post-test: F4,195= 376.3, **P < 0.01, *P < 0.05). c Quantiﬁcation of the immune
cells after tnf-α gRNA injection shows that Tnf-α disruption leads to increased numbers of neutrophils (Mpx+) at 1 dpl but not at 2 dpl, whereas the
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indicates that tnf-α disruption leads to increased levels of il-1β mRNA at 2 dpl (t-tests: *P < 0.05). Lateral views of the injury site are shown; rostral is left.
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Reduction of Il-1β levels rescues swimming in irf8 mutants. To
determine whether ll-1β inhibition also rescued recovery of
swimming function in irf8 mutants, we analysed touch-evoked
swimming distances. YVAD had no effect in unlesioned mutant
or wildtype animals and did not affect recovery in lesioned
wildtype animals (Fig. 7e). In contrast, YVAD-treatment rescued
the touch-evoked swimming distance in irf8mutants to levels that
were indistinguishable from wildtype lesioned or unlesioned
animals (Fig. 7e). Mean velocity and path shape (meandering)
were also rescued (Supplementary Fig. 10I, J). These observations
indicate that inhibition of Il-1β alone restores most axonal
regeneration and recovery of touch-evoked swimming parameters
in the absence of macrophages.
Neutrophils are a major source of il-1β. To understand il-1β
regulation, we determined the source of Il-1β in wildtype and irf8
mutants. Using Il-1β immunohistochemistry and a transgenic
reporter line (il-1β:GFP), we found expression in microglia,
macrophages, neutrophils and basal keratinocytes in the injury
site (Fig. 8c, d; Supplementary 12A). Neuronal labelling
(HuC/D+) did not overlap with il-1β:GFP labelling (Supple-
mentary Fig. 12B). While numbers of il-1β:GFP+ immune cells
did not change signiﬁcantly between 1 and 2 dpl, the percentage
of macrophages (from 50.6 to 34.3%) and neutrophils that were
labelled for the il-1β:GFP transgene were reduced (from 53.3 to
23.7%), likely reﬂecting resolution of inﬂammation (Supplemen-
tary Fig. 12A).
In irf8 mutants, detection of il-1β mRNA by qRT-PCR and
in situ hybridisation conﬁrmed increased levels at 2 dpl, but not 1
dpl (Fig. 8a, b), despite lack of il-1β expressing microglia and
macrophages. Instead, we observed increased numbers of Il-1β+
neutrophils (by 97%) and basal keratinocytes (by 58%) compared
to wildtype animals at 1 dpl (Fig. 8c, d). Importantly, the
proportion of neutrophils that were Il-1β+ was also increased
from 33.6% in wildtype animals to 49% in the irf8 mutant at 1
dpl. This demonstrates that neutrophils are more likely to express
il-1β in the absence of macrophages.
Increased numbers of Il-1β+ neutrophils in irf8 mutants
could, at least in part, be due to higher overall numbers of
neutrophils in the injury site. We found a peak of neutrophil
numbers in the lesion site of irf8 mutants at 2 hpl, as in wildtype
animals (Fig. 9a). However, the number of neutrophils was 27%
higher than in wildtype, potentially due to the higher abundance
of this cell type in the irf8 mutant18. While neutrophil
numbers declined over time in wildtype and irf8 mutants, they
did so more slowly in irf8 mutants. At 24 hpl, twice, and at 48
hpl, three times the number of neutrophils as in wildtype
animals remained in the mutant. Hence, macrophages control
number of and cytokine expression by neutrophils32, leading to
prolonged presence of Il-1β+ neutrophils in the injury site of
irf8 mutants.
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Neutrophils inhibit regeneration in irf8 mutants. To determine
the relative importance of the neutrophils for regenerative failure
in irf8 mutants, we reduced their numbers using pu.1/gcsfr
morpholino treatment. This strongly reduced numbers of neu-
trophils by 84.6% in the injury site at 2 hpl, when the neutrophil
reaction peaked in untreated irf8 mutants (Fig. 9b). pu.1/gcsfr
morpholino treatment also reduced il-1β mRNA levels by 54%
and tnf-α mRNA levels by 70% at 2 dpl (Fig. 9c). Remarkably,
axon bridging (control: 43% of examined animals showed brid-
ging; pu.1/gcsfr morpholino: 60%; Fig. 9d) and recovery of touch-
evoked swimming distance were partially rescued in these
neutrophil-depleted mutants at 2 dpl (Fig. 9e). This shows that in
the absence of macrophages, the prolonged presence of Il-1β+
neutrophils is detrimental to regeneration.
Discussion
We identify a biphasic role of the innate immune response for
axonal bridging of the non-neural lesion site in larval zebraﬁsh.
Initial inﬂammation and Il-1β presence promote axon bridging,
whereas later, Il-1β levels need to be tightly controlled by per-
ipheral macrophages. Inhibiting Il-1β largely compensated for the
absence of macrophages, underscoring the central role of this
cytokine. Macrophage-derived Tnf-α promotes regeneration,
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partially by reducing neutrophil number and il-1β levels (sum-
marised in Supplementary Fig. 13). This indicates important and
highly dynamic functions of the immune system for successful
spinal cord regeneration.
The function of the immune system changes dramatically over
time. Within the ﬁrst hours after injury, neutrophils and the pro-
inﬂammatory cytokines il-1β and tnf-α dominate the injury site.
Initially, inﬂammation promotes axonal growth. This is indicated
by reducing effects on axon bridging of early Il-1β inhibition and
the promoting effect of LPS in wildtype animals. Indeed, it has
been reported that Il-1β can promote neurite growth33,34. How-
ever, from about 12 hpl, macrophages and anti-inﬂammatory
cytokines are in the lesion site and during this late phase of
regeneration, Il-1β mediated inﬂammation in macrophage-less
mutants strongly inhibits regeneration.
How does Il-1β inhibit spinal cord regeneration? High Il-1β
levels may condition the environment to be inhibitory to axonal
regrowth. Blocking excessive Il-1β signalling in irf8 mutants
revealed that Il-1β increases numbers of neutrophils, levels of il-
1β and tnf-α expression, as well as cell death in the lesion
environment. Morevover, reduced expression of some metallo-
proteinases in the irf8 mutant suggest that the lesion site ECM
may be altered. However, several ECM components, including
functionally important Col XII1, were unaltered in expression in
the irf8 mutant. Similar to our observations, an Il-1β deﬁcient
mouse showed slightly increased axonal regrowth after spinal
injury35.
Axonal regeneration is promoted by Tnf-α. Even though il-1β
and tnf-α were similarly upregulated in the irf8 mutant, only
reducing Il-1β levels rescued the mutant. Conversely, in wildtype
animals, Il-1β had only a relatively small promoting effect on
early regeneration, whereas Tnf-α was indispensable for axonal
regrowth. Different functions for the two pro-inﬂammatory
cytokines have been reported36. They also differ in cell type of
origin. Whereas Il-1β is expressed by a substantial proportion of
neutrophils, microglia and macrophages, Tnf-α is mainly
expressed by macrophages in the injury site. This indicates a clear
difference between tissue-resident microglia and peripheral
macrophages. In mammals, tnf-α is produced by both microglia
and macrophages37.
Tnf-αmay exert its positive role for regeneration at least in part
by controlling neutrophil numbers and Il-1β levels. Both of these
parameters are increased when Tnf-α is inhibited and are inhi-
bitory to regeneration. Anti-inﬂammatory actions of Tnf-α have
been described in the context of auto-immunity38, but whether
this interaction between Tnf-α and Il-1β is direct or indirect,
needs to be elucidated. For example, Tnf-α can be neuroprotec-
tive after CNS injury36,39 and thus indirectly reduce inﬂamma-
tion. In the regenerating ﬁn, Tnf-α has an important promoting
function for blastema formation40. This suggests that Tnf-α may
be involved in remodelling repair cells in the lesion site after
spinal injury, which then creates an axon growth-promoting
environment.
The role of Tnf-α for axonal regeneration in mammals is not
clear. Some reports indicate axon growth promoting properties of
Tnf-α41,42, whereas others show inhibition of axon growth43.
Negative effects of Tnf-α on lesion-induced cell death44 and
functional recovery37,45 have also been reported. However, knock
out of Tnf-α had no reported effect after spinal injury46.
Preventing neutrophil formation in irf8 mutants, indicates that
il-1β expressing neutrophils are major mediators of the inhibitory
immune response in the absence of microglia and macrophages.
However, the rescue of axon regrowth and swimming function
was only partial. This could be explained by the absence of the
early regeneration-promoting inﬂuence of the inﬂammation or
basal keratinocytes still expressing il-1β in neutrophil-depleted
irf8 mutants. In mammals, neutrophils cause secondary cell
death47,48 and depleting neutrophils leads to favourable injury
outcomes5, similar to our observations.
Macrophages control inﬂammation, as their absence in irf8
mutants leads to abnormally high expression levels of pro-
inﬂammatory cytokines il-1β and tnf-α. This is similar to obser-
vations in ﬁn regeneration49. In the absence of macrophages,
positive feedback regulation of il-1β takes place, as indicated by
more il-1β positive neutrophils and basal keratinocytes in the irf8
mutants and reduced il-1β mRNA levels when Il-1β function was
inhibited. Moreover, a higher proportion of neutrophils were Il-
1β+ in irf8 mutants, showing that without macrophages, neu-
trophils have a more pro-inﬂammatory phenotype. We show that
macrophages/microglia, together with other tissues, express anti-
inﬂammatory cytokines tgf-β1a and tgf-β3 and could thus be
partly responsible for reducing pro-inﬂammatory phenotypes in
wildtype animals.
Macrophages do not promote regeneration primarily by pre-
venting cell death or removing debris. We observed phagocy-
tosing macrophages by time-lapse imaging and debris levels were
clearly increased it the absence of macrophages in irf8 mutants.
However, when axon regrowth was rescued in the mutant by Il-1β
inhibition, debris levels were still higher than in controls. Pre-
venting cell death did not rescue axon growth and inhibition
phagocytosis in wildtype animals did not impair regeneration.
Hence, regenerative success does not correlate with debris
abundance. Interestingly, in ﬁn regeneration, lack of macrophages
also leads to increased cell death. As this leads to death of tissue
progenitor cells, ﬁn regeneration is inhibited49. In mammalian
spinal injury, debris, especially myelin debris, is inhibitory to
regeneration50.
Are macrophages the most important immune cell type for
axonal regrowth? Unimpaired axonal regrowth in the csfr1a/b
mutant, in which microglial cells are absent and neutrophils are
strongly reduced in number, indicates that these cells may be
dispensable for regeneration. However, the increase in peripheral
macrophages in this mutant could have compensated for a pos-
sible regeneration-promoting role of microglia. Since some neu-
trophils are still present in the injury site in csfr1a/b mutants,
these might contribute to promoting axonal regrowth.
Endothelial cells and myelinating cells are unlikely to be major
mediators of early regeneration in larval spinal cord regeneration.
Endothelial cells from injured blood vessels were slow to reform
blood vessels and were rarely invading the lesion site. In contrast,
in mammals endothelial cells accumulate in the injury site, where
they may have anti-inﬂammatory functions51. Myelinating cells
bridged the lesion site, but were not abundant and only did so,
when axons had already crossed the lesion site. Although rela-
tively late, axons become remyelinated, which may contribute to
recovery of some swimming parameters after injury. In mammals,
transplanted myelinating cells, such as olfactory ensheathing cells
and Schwann cells have been shown to improve recovery after
spinal injury52,53.
Astroglia-like processes cross the injury site and this depends on
the immune response, as we show here. While these processes cross
the injury site independently of and slightly later than axons and
axons still cross when these cells are ablated1, astroglia-like pro-
cesses produce growth factors that support axonal regeneration54,55.
Timing of the immune response is crucial for regenerative
success after spinal lesion. Macrophages in mammals3,37 and
zebraﬁsh56 display pro-inﬂammatory and anti-inﬂammatory
phenotypes and the anti-inﬂammatory phenotypes are seen as
beneﬁcial for regeneration7–9. We show that inﬂammation is
rapidly downregulated in zebraﬁsh concurrent with the upregu-
lation of anti-inﬂammatory cytokines, which does not readily
occur in mammals3.
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In summary, we have established an accessible in vivo system to
study complex interactions of immune cells and a spinal injury site
in successful regeneration. This allows fundamental insight into the
role of immune cells that may ultimately inform non-regenerating
systems. Here, we demonstrate a pivotal role of macrophages in
promoting functional spinal cord regeneration, by producing Tnf-α
and controlling Il-1β-mediated inﬂammation.
Methods
Animals. All zebraﬁsh lines were kept and raised under standard conditions57 and
all experiments were approved by the British Home Ofﬁce (project license no.: 70/
8805). Regeneration proceeds within 48 h of the lesion, therefore most analyses of
axonal regrowth, cellular repair, and behavioural recovery can be performed before
the ﬁsh are protected under the A(SP)A 1986, reducing the number of animals used
in regeneration studies following the principles of the 3 rs. Approximately 11,000
larvae of either sex were used for this study, of which 8% were over 5 dpf.
The following lines were used: WIK wild type zebraﬁsh, Tg(Xla.Tubb:DsRed)
zf14826, abbreviated as Xla.Tubb:DsRed58; Tg(mpeg1:EGFP)gl22, abbreviated as
mpeg1:GFP59, and Tg(mpx:GFP)uwm1, abbreviated as mpx:GFP60, Tg(ﬂi1:EGFP)y1,
abbreviated as ﬂi1:GFP61; irf8st95/st95, abbreviated as irf8mutants18; csf1raj4e1/j4e1 ×
csf1rb+/re01 incrosses, phenotypically sorted for absence of 4C4+ cells in the head,
abbreviated as csfr1a/b mutants19; TgBAC(pdgfrb:Gal4FF)ncv24; Tg(UAS:GFP),
abbreviated as pdgfrb:GFP62,Tg(6xTCF/LefminiP:2dGFP), abbreviated as 6xTCF:
dGFP63, Tg(claudin k:Gal4)ue101; Tg(14xUAS:GFP) abbreviated as cldnK:GFP64, Tg
(tnfa:eGFP-F)sa43296, abbreviated as tnf-α:GFP56 and Tg(il-1β:eGFP)sh445,
abbreviated as il-1β:GFP65.
Drug treatment. Dexamethasone (Dex) (Sigma, Gillingham, UK) was dissolved in
DMSO to a stock concentration of 5 mM. The working concentration was 10 μM
prepared by dilution from stock solution in ﬁsh water. Ac-YVAD-cmk (YVAD)
(Sigma) was dissolved in DMSO to a stock concentration of 10 mM. The working
concentration was 50 μM prepared by dilution from the stock solution in ﬁsh
water. Q-VD-OPh (Sigma), abbreviated as QVD in the manuscript, was dissolved
in DMSO to a stock concentration of 10 mM. The working concentration was 50
μM. O-Phospho-L-serine (L-SOP) (Sigma) was dissolved in PBS to a stock con-
centration of 10 mM. The working concentration was 10 μM prepared by dilution
from stock solution. Lipopolysaccharides from Escherichia coli O55:B5 (LPS,
Sigma) were dissolved in PBS to a stock concentration of 1 mg/ml. The working
dilution was 50 μg/ml. Pomalidomide (Cayman Chemicals, Michigan, USA) was
diluted in DMSO at a stock concentration of 10 mg/ml. For the treatments, 6.9 μl of
the stock where diluted in 1.5 ml of ﬁsh water. Larvae were pre-treated for 2 h
before the injury and were incubated for 24 and 48 hpl. Larvae were collected from
the breeding tanks and were randomly divided into Petri dishes at a density of
maximally 30 larvae per dish, but no formal randomisation method was used. For
most drug treatments, larvae were incubated with the drug from 3 dpl until 5 dpl, if
not indicated differently.
Spinal cord lesions. Zebraﬁsh larvae at 3 dpf were anaesthetised in PBS containing
0.02% aminobenzoic-acid-ethyl methyl-ester (MS222, Sigma), as described1. Larvae
were transferred to an agarose-coated petri dish. Following removal of excess water,
the larvae were placed in a lateral position, and the tip of a sharp 30 ½ G syringe
needle was used to inﬂict a stab injury or a dorsal incision on the dorsal part of the
trunk at the level of the 15th myotome.
Behavioural analysis. Behavioural analysis was performed as previously descri-
bed14. Brieﬂy, lesioned and unlesioned larvae were touched caudal to the lesion site
using a glass capillary. The swim distance of their escape response, the mean
velocity and the meandering were recorded for 15 s after touch and analyzed using
a Noldus behaviour analysis setup (EthoVision version 7). Data given is averaged
from triplicate measures per ﬁsh. Between repeated measures, the larvae were left to
recover for 1 min. The observer was blinded to the treatment during the beha-
vioural assay. The assay was performed on ﬁve independent clutches in order to
assess the behavioural recovery in the irf8 mutants and three independent clutches
after the YVAD treatment.
Fluorescence-activated cell sorting. Macrophages and microglia were isolated
from 4 dpf transgenic mpeg1:eGFP embryos by FACS. For this purpose, about 500
ﬁsh were lesioned by transecting the spinal cord. Trunk-containing lesion site were
dissected and collected at 24 hpl and used for cell dissociation66. Cells puriﬁed after
FACS were used for qRT-PCR.
Quantitative RT-PCR. RNA was isolated from the injury sites of the larvae using
the RNeasy Mini Kit (Qiagen, Hilden, Germany). Forty larvae were used for each
condition. cDNA used as template was created using the iScript™ cDNA Synthesis
Kit (Bio-Rad, Munich, Germany). Standard RT-PCR was performed using SYBR
Green Master Mix (Bio-Rad). qRT-PCR was performed at 58 °C using Roche Light
Cycler 96 (Roche Diagnostics, West Sussex, UK) and relative mRNA levels
determined using the Roche Light Cycler 96 SW1 software. Samples were run in
duplicates and expression levels were normalised to β-actin control. Primers were
designed to span an exon-exon junction using Primer-BLAST. Sequences are given
in supplementary Table 2. All experiments were carried out at least as biological
triplicates.
In situ hybridisation. For whole mount in situ hybridisation1, after ﬁxation in 4%
PFA, larvae were digested with 40 μg/ml Proteinase K (Invitrogen, Carlsbad, USA).
Thereafter, larvae were washed brieﬂy in PBT and were re-ﬁxed for 20 min in 4%
PFA followed by washes in PBT. After washes, larvae were incubated at 67 °C for 2
h in pre-warmed hybridisation buffer. Hybridisation buffer was replaced with
digoxigenin (DIG) labelled ISH probes diluted in hybridisation buffer and incu-
bated at 67 °C overnight. The next day, larvae were washed thoroughly at 67 °C
with hybridisation buffer, 50% 2× SSCT/50% deionized formamide, 2x SSCT and
0.2x SSCT. Larvae were then washed in PBT and incubated for 1 h in blocking
buffer under slow agitation. Thereafter, larvae were incubated overnight at 4 °C in
blocking buffer containing pre-absorbed anti-DIG antibody. The next day, larvae
were washed in PBT, followed by washes in staining buffer. Colour reaction was
performed by incubating larvae in staining buffer supplemented with NBT/BCIP
(Sigma-Aldrich) substrate. The staining reaction was terminated by washing larvae
in PBT.
Immunoﬂuorescence. All incubations were performed at room temperature unless
stated otherwise. Antibodies used are listed in supplementary Table 3. For most
immunolabelling experiments, the larvae were ﬁxed in 4% PFA-PBS containing 1%
DMSO at 4 °C overnight. After washes in PBS, larvae were washed in PBTx. After
permeabilization by incubation in PBS containing 2 mg/ml Collagenase (Sigma) for
25 min larvae were washed in PBTx. They were then incubated in blocking buffer
for 2 h and incubated with primary antibody (1:50–1:500) diluted in blocking
buffer at 4 °C overnight. On the following day, larvae were washed times in PBTx,
followed by incubation with secondary antibody diluted in blocking buffer (1:300)
at 4 °C overnight. The next day, larvae were washed three times in PBTx and once
in PBS for 15 min each, before mounting in glycerol.
For whole mount immunostaining using primary antibodies from the same host
species (rabbit anti-Il-1β, rabbit anti-Mpx, rabbit anti-Tp63) the samples were
initially incubated with the ﬁrst primary antibody at 4 °C overnight. After washes
with PBTx the samples were incubated with the conjugated ﬁrst secondary
antibody overnight at 4 °C. Subsequently, samples were incubated with blocking
buffer for 1 h at RT in order to saturate open binding sites of the ﬁrst primary
antibody. Next, the samples were incubated with unconjugated Fab antibody
against the host species of the primary antibody in order to cover the IgG sites of
the ﬁrst primary antibody, so that the second secondary antibody will not bind to
it. After this, samples were incubated with the second primary antibody overnight
at 4 °C and subsequently with the second conjugated secondary antibody overnight
at 4 °C before mounting in glycerol. No signal was detected when the second
primary antibody was omitted, indicating speciﬁcity of the consecutive
immunolabeling protocol.
For whole mount immunostaining of acetylated tubulin1, larvae were ﬁxed in
4% PFA for 1 h and then were dehydrated and transferred to 100% MeOH and
then stored at −20 °C overnight. The next day, head and tail were removed, and the
samples were incubated in pre-chilled Acetone. Thereafter, larvae were washed and
digested with Proteinase K and re-ﬁxed in 4% PFA. After washes the larvae were
incubated with BSA in PBTx for 1 h. Subsequently the larvae were incubated for 2
overnights with primary antibody (acetylated tubulin). After washes and
incubation with the secondary antibody the samples were washed in PBS for 15
min each, before mounting in glycerol.
Evaluation of cell death using acridine orange. In order to assess the levels of cell
death after injury we used the acridine orange live staining as described by others67.
Brieﬂy, at 1 and 2 dpl the larvae were incubated in 2.5 μg/ml solution of dye diluted
into conditioned water for 20 min. After the staining, the larvae were washed by
changing the water and larvae were live-mounted for imaging.
Identiﬁcation of dying cells after injury. In order to assess the levels of cell death
after injury cross sections of larvae were used. Larvae were ﬁxed in 4% PFA
overnight at 4 °C. After washes with 0.5% PBSTx, the larvae were transferred to
100% methanol and incubated for 10 min at room temperature. After rehydration,
the larvae were washed with PBSTx 0.5%. Following this, larvae were mounted in
4% agarose and 50 μm sections were performed using a vibratome (MICROM HM
650 V, VWR, Leicestershire, UK). The sections were then permeabilized using 14
μg/ml diluted in 0.5% PBSTx. After brief wash with PBSTx the sections were
postﬁxed in 4% PFA for 20 min. Excess PFA was washed out and the samples were
incubated with the TUNEL reaction mix according to the In-situ Cell Death
Detection Kit TMR red protocol (Roche).
Western blotting. Zebraﬁsh larvae were sacriﬁced by an overdose of MS-222 at 4
dpf and used for protein extraction. Around 60 ﬁsh per condition were homo-
genised in 250 µl of 1x PBS/1% Triton X-100 (containing protease inhibitor
cocktail complete, Roche Diagnostics), using a tissue grinder. After 1 h incubation
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at 4 degrees, lysates were centrifuged at 12,000 rpm for 20 mins to remove Triton-
X-100-insoluble debris. Protein concentrations were quantiﬁed using a BCA assay
following manufacturer’s instruction and the same amount of protein for each
sample was loaded on a denaturating 12% acrylamide gel. After the electrophoretic
run, the proteins were transferred on a nitrocellulose membrane (BioRad, Ger-
many) and, after 1 h blocking in PBS/5% non-fat dry milk/0.1% Tween-20, probed
with either rabbit anti-TNFα (1:2000, Anaspec; Fremont, CA), rabbit anti IL-1
(1:200, Proteintech, Manchester, UK) or mouse anti-α Tubulin (1:2000, DSHB) O/
N at 4 degrees. Goat anti-rabbit (IRdye680LT, LI-COR, Lincoln, Nebraska, USA)
and goat anti-mouse (IRdye800CW, LI-COR) secondary antibodies were used and
the signal was detected by an Odyssey (LI-COR) imaging system and analysed with
the Image Studio Lite software version 5.2.
Morpholino injection. All morpholinos were injected into single cell stage larvae in
total volume of 2 nl. Knockdown of il-1β was carried out using the antisense
morpholino against il-1β (5ʹ-CCCACAAACTGCAAAATATCAGCTT-3ʹ), target-
ing the splice site between intron 2 and exon 3 according to31. In order to block
neutrophil development, we used the previously described MO combination of pu.1
(5′-GATATACTGATACTCCATTGGTGGT-3′) which targets the translational
start (ATG) of the pu.1 and the splice blocking MO against gcsfr (5′-
TTTGTCTTTACAGATCCGCCAGTTC-3′)16. All morpholinos and standard
control (5′-CCTCTTACCTCAGTTACAATTTATA-3′) were obtained from Gene
Tools, LLC, Oregon, USA.
CRISPR-mediated genome editing. CRISPR gRNA for il-1β was designed using
CRISPR Design (http://crispr.mit.edu) and ZiFit (http://ziﬁt.partners.org/ZiFiT)
webtools. Vectors were generated by ligating the annealed oligonucleotides into the
pT7-gRNA expression vector1. The gRNA was transcribed using the mMESSAGE
mMACHINE T7 kit (Ambion, ThermoFisher SCIENTIFIC, Loughborough, UK)
and assessed for size and quality on an electrophoresis gel. The injection mix
consisted of 75 pg il-1β gRNA (target sequence: 5′-TGTGGAGCGGAGCCT
TCGGCGGG-3′) and 150 pg Cas9 RNA and was injected into single cell stage
larvae. The CrRNA for tnf-α (target sequence: 5′-CCCGATGATGGCATTTA
TTTTGT-3′) and the tracrRNA were ordered from Merck KGaA (Germany,
Darmstadt). The injection mix included 1 μl Tracer 250 ng/μl, 1 μl gRNA, 1 μl Cas9
protein, 1 μl RNAse free H20, 1 μl ﬂuorescent dextran. Larvae injected with GFP
gRNA (target sequence: 5′GGCGAGGGCGATGCCACCTA-3) and uninjected
larvae were used as controls. The efﬁciency of the mutagenesis was assessed by
RFLP analysis.
Live imaging of zebraﬁsh larvae and time-lapse imaging. For the acquisition of
all ﬂuorescent images, LSM 710 and LSM 880 confocal microscopes were used. For
live confocal imaging, zebraﬁsh larvae were anesthetized in PBS containing 0.02%
MS222 and mounted in 1.5% low melting point agarose (Ultra-PureTM, Invitro-
gen). During imaging, the larvae were covered with 0.01% MS222-containing ﬁsh
water to keep preparations from drying out. For time-lapse imaging, agarose
covering the lesion site was gently removed after gelation. Time-lapse imaging was
performed for 19 h starting at 6 hpl. Acquired time-lapse images were denoised
using the ImageJ plugin CANDLE-J algorithm. Comparison of raw movies with
CANDLE-J-processed movies showed that edges of features remained conserved
after denoising.
Scoring and measurement of spinal cord bridging. Axonal and astroglial brid-
ging was scored in ﬁxed and live mounted samples using ﬂuorescence-equipped
stereomicroscope (Leica MDG41) and confocal microscopes (LSM 710, LSM 880)
at time points of interest as previously described1. Any continuity of labelling
between the two spinal cord stumps was scored as “bridged”. In some cases, the
thickness of the axonal bridge was measured in collapsed confocal image stacks, by
determining the length of (a) vertical line(s) that covers the width of crossing
fascicles at the centre of the injury site. The observer was blinded to the experi-
mental condition before scoring or measuring and experiments were performed
blinded to the experimental condition on at least three independent clutches of
larvae.
Cell counting in whole-mounted larvae. A volume of interest was deﬁned centred
on the lesion site from confocal images. The dimensions were: width= 200 μm,
height= 75 μm (above the notochord), depth= 50 μm. Images were analysed using
the Imaris (Bitplane, Belfast, UK) or ImageJ software. The number of cells was
quantiﬁed manually in 3D view, blinded to the experimental condition on at least
three independent clutches of larvae.
Quantiﬁcation of diffuse signals in whole-mount larvae. For most quantiﬁca-
tions of diffuse signal, e.g., acridine orange, image stacks, centred in the lesion site
(height: 50 µm) were collapsed and an area of interest deﬁned: width= 100 μm,
height= 50 μm (above the notochord). The image was thresholded and the
‘’Analyze Particles” tool in Fiji with default settings was used to calculate the
percentage of area taken up by signal.
To quantify Col I and Tnf-α in the injury site (Supplementary Figs 4C and 9A)
we used a previously published protocol1. Brieﬂy, image stacks were collapsed,
thresholded and the area of the signal was measured.
All analyses were performed blinded to the experimental condition on at least
three independent clutches of larvae.
Statistical analysis. Power analysis using G*Power68, was used to calculate power
(aim > 0.8) for the experiments and determine the group sizes accordingly. Sta-
tistical power was >0.8 for all experiments. All quantitative data were tested for
normality and analyzed with parametric and non-parametric tests as appropriate.
The statistical analysis was performed using IBM SPSS Statistics 23.0. Shapiro-
Wilk’s W-test was used in order to assess the normality of the data. Quantitative
RT-PCR data were analyzed as previously described69,70. Kruskal–Wallis test fol-
lowed by Dunn’s multiple comparisons, One-way ANOVA followed by Bonferroni
multiple comparisons test, two-way ANOVA, followed by Bonferroni multiple
comparisons, t-test, Mann–Whitney U-test or Fischer’s exact test were used, as
indicated in the ﬁgure legends. *P < 0.05, **P < 0.01, ***P < 0.001, n.s. indicates no
signiﬁcance. Error bars indicate the standard error of the mean (SEM). The Figures
were prepared with Adobe Photoshop CC and Adobe Illustrator CC. Graphs were
generated using GraphPad Prism 7.
Data availability
The authors declare that all data supporting the ﬁndings of this study are available
within the article and its supplementary information ﬁles, or from the corre-
sponding authors on reasonable request.
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